EXICURE, INC. Revenue from Grants (Deprecated 2018-01-31)
EXICURE, INC. (XCUR) reported Revenue from Grants (Deprecated 2018-01-31) of $0 for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-09.
Discontinued › Income Statement › Other Income
us-gaap:RevenueFromGrants · last filed 2018-03-09
- EXICURE, INC. revenue from grants (deprecated 2018-01-31) for the quarter ending 2017-12-31 was $0.00.
- EXICURE, INC. revenue from grants (deprecated 2018-01-31) for the quarter ending 2017-09-30 was $0.00.
- EXICURE, INC. revenue from grants (deprecated 2018-01-31) for the quarter ending 2016-12-31 was $0.00.
- EXICURE, INC. revenue from grants (deprecated 2018-01-31) for the quarter ending 2016-09-30 was $0.00.
- EXICURE, INC. revenue from grants (deprecated 2018-01-31) for fiscal 2017 was $0.00, a 100.00% decline from fiscal 2016.
- EXICURE, INC. revenue from grants (deprecated 2018-01-31) for fiscal 2016 was $346.00K.
| Period end | Revenue from Grants (Deprecated 2018-01-31) 3 month | Revenue from Grants (Deprecated 2018-01-31) 6 month | Revenue from Grants (Deprecated 2018-01-31) 9 month | Revenue from Grants (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | $0.00 derived: sum of 2 quarters · filed 2018-03-09 | $0.00 10-K · filed 2018-03-09 | |
| 2017-09-30 | $0.00 10-Q · filed 2017-11-14 | $0.00 10-Q · filed 2017-11-14 | ||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | $0.00 derived: sum of 2 quarters · filed 2018-03-09 | $346.00K 10-K · filed 2018-03-09 | |
| 2016-09-30 | $0.00 10-Q · filed 2017-11-14 | $346.00K 10-Q · filed 2017-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |